Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...
One of the most important bioprocessing advances in recent years has been the rise in levels of manufactured therapeutic proteins. Indeed, the overall average yield reported for commercial monoclonal ...
WEST SACRAMENTO, Calif., March 28, 2023 /PRNewswire/ -- Gemini Bioproducts, LLC ("GeminiBio"), a leading manufacturer of cell culture products and custom cGMP bioprocess liquids for the biotech ...
LONDON and BAD HOMBURG, Germany, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, and Fresenius Kabi, an operating company of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results